Sage Therapeutics Ownership | Who Owns Sage Therapeutics?
Sage Therapeutics Ownership Summary
Sage Therapeutics is owned by 19.27% institutional investors, 10.41% insiders, and 70.32% retail investors. Blackrock is the largest institutional shareholder, holding 8.67% of SAGE shares. BB Biotech AG Ord is the top mutual fund, with 7.29% of its assets in Sage Therapeutics shares.
SAGE Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Sage Therapeutics | 19.27% | 10.41% | 70.32% |
Sector | Healthcare Stocks | 279.19% | 10.62% | -189.81% |
Industry | Biotech Stocks | 63.96% | 10.74% | 25.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Blackrock | 5.22M | 8.67% | $56.64M |
Blackrock funding, inc. /de | 4.85M | 7.94% | $26.34M |
Vanguard group | 4.84M | 7.92% | $26.27M |
Madison avenue partners, lp | 4.48M | 7.24% | $35.60M |
Fmr | 4.12M | 6.74% | $22.36M |
Caligan partners lp | 3.05M | 4.93% | $24.27M |
Deep track capital, lp | 2.04M | 3.30% | $16.21M |
Acadian asset management | 1.59M | 2.59% | $8.60M |
Jacobs levy equity management | 1.43M | 2.37% | $15.48M |
Morgan stanley | 1.39M | 2.31% | $15.10M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Caligan partners lp | 3.05M | 5.06% | $24.27M |
Madison avenue partners, lp | 4.48M | 3.02% | $35.60M |
Adar1 capital management | 742.50K | 1.10% | $5.90M |
Kite lake capital management (uk) llp | 105.00K | 1.09% | $834.75K |
Deep track capital, lp | 2.04M | 0.52% | $16.21M |
Dafna capital management | 108.20K | 0.24% | $860.19K |
683 capital management | 630.00K | 0.21% | $3.42M |
Clearalpha technologies lp | 40.00K | 0.20% | $318.00K |
Boothbay fund management | 1.39M | 0.19% | $7.54M |
Pdt partners | 235.10K | 0.11% | $1.28M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Madison avenue partners, lp | 4.48M | 3.02% | 4.48M |
Deep track capital, lp | 2.04M | 0.52% | 2.04M |
Boothbay fund management | 1.39M | 0.19% | 1.39M |
Jacobs levy equity management | 1.43M | 0.06% | 870.16K |
Adar1 capital management | 742.50K | 1.10% | 723.29K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Wellington management group llp | 39.65K | 0.00% | -4.71M |
Bellevue group | - | - | -4.46M |
Rtw investments, lp | - | - | -3.00M |
State street | 1.27M | 0.00% | -1.65M |
Millennium management | 309.54K | 0.00% | -1.31M |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Madison avenue partners, lp | 4.48M | 3.02% | 4.48M | $35.60M |
Deep track capital, lp | 2.04M | 0.52% | 2.04M | $16.21M |
Boothbay fund management | 1.39M | 0.19% | 1.39M | $7.54M |
Susquehanna fundamental investments | 215.87K | 0.02% | 215.87K | $1.17M |
Tudor investment corp et al | 142.91K | 0.00% | 142.91K | $1.14M |
Sold Out
Holder | Change |
---|---|
Dinuzzo private wealth | -5.00 |
Principal securities | -6.00 |
Jfs wealth advisors | -8.00 |
Sjs investment consulting | -8.00 |
Nelson, van denburg & campbell wealth management group | -10.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Mar 31, 2025 | 16 | -91.26% | 11,920,805 | -76.73% | 19 | 0.27% | 11 | -85.71% | 3 | -94.83% |
Dec 31, 2024 | 180 | -2.70% | 51,167,968 | -0.51% | 83 | 1.18% | 75 | -6.25% | 59 | 15.69% |
Sep 30, 2024 | 185 | -8.87% | 51,430,442 | -3.85% | 84 | 1.06% | 81 | -25.69% | 51 | -3.77% |
Jun 30, 2024 | 200 | -5.21% | 53,449,131 | -8.16% | 88 | 0.94% | 106 | 9.28% | 53 | -8.62% |
Mar 31, 2024 | 211 | -1.40% | 58,196,544 | 3.77% | 97 | 1.11% | 97 | 10.23% | 58 | -23.68% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
BB Biotech AG Ord | 4.46M | 7.29% | - |
Fidelity Growth Compy Commingled Pl O | 2.39M | 3.91% | - |
Vanguard Total Stock Mkt Idx Inv | 1.82M | 2.91% | 109.30K |
Vanguard US Total Market Shares ETF | 1.71M | 2.78% | - |
SPDR® S&P Biotech ETF | 1.63M | 2.66% | 23.14K |
iShares Russell 2000 ETF | 1.40M | 2.24% | 687.00 |
Vanguard Strategic Equity Inv | 1.07M | 1.71% | 412.85K |
Vanguard Institutional Extnd Mkt Idx Tr | 873.73K | 1.40% | 1.57K |
Federated Hermes MDT Small Cap Core IS | 821.66K | 1.31% | 52.21K |
Federated Hermes MDT SCC Institutional | 821.66K | 1.31% | 52.21K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Aug 09, 2023 | Barrett Elizabeth | - | Buy | $37.28K |
May 09, 2023 | Barrett Elizabeth | - | Buy | $50.50K |
Feb 10, 2023 | JONAS JEFFREY M | - | Sell | $347.08K |
Feb 10, 2023 | JONAS JEFFREY M | - | Sell | $172.33K |
Nov 10, 2022 | Greene Barry E | President and CEO | Buy | $500.02K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q2 | - | - |
2025 Q1 | - | - |
2024 Q4 | - | - |
2024 Q3 | - | - |
2024 Q2 | - | - |
SAGE Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools